Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

NITROFURANTOIN 25 MG/5 ML SUSP

NITROFURANTOIN
$2.2074per ML

Strength

25 mg/5mL

Manufacturer

Biocon Pharma Inc.

NDC

70377011831

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

NITROFURANTOIN

Approval Type

Generic (ANDA)

FDA Application

ANDA218346

On Market Since

11/15/2024

Pharmacological Classes

Nitrofuran Antibacterial
Nitrofurans

Price History

1W

0.0%

1M

+3.0%

3M

+1.0%

6M

-17.9%

1Y

-28.2%

3Y

N/A

5Y

N/A

All

-43.0%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

NITROFURANTOIN MCR 50 MG CAP
Generic
00115164301•Amneal Pharmaceuticals of New York LLC
$0.1411
per EA
NITROFURANTOIN MCR 50 MG CAP
Generic
00904702661•Major Pharmaceuticals
$0.1411
per EA
NITROFURANTOIN MCR 50 MG CAP
Generic
43386064101•Lupin Pharmaceuticals Inc.
$0.1411
per EA
NITROFURANTOIN MCR 50 MG CAP
Generic
50268062315•AvPAK
$0.1411
per EA
NITROFURANTOIN MCR 50 MG CAP
Generic
59651075301•Aurobindo Pharma Limited
$0.1411
per EA
NITROFURANTOIN MCR 50 MG CAP
Generic
60687083901•American Health Packaging
$0.1411
per EA
NITROFURANTOIN MCR 50 MG CAP
Generic
68001060400•BluePoint Laboratories
$0.1411
per EA
NITROFURANTOIN MCR 50 MG CAP
Generic
68382055901•Zydus Pharmaceuticals (USA) Inc.
$0.1411
per EA
NITROFURANTOIN MCR 50 MG CAP
Generic
70756041111•Lifestar Pharma LLC
$0.1411
per EA
NITROFURANTOIN MCR 50 MG CAP
Generic
72603018301•NorthStar Rx LLC
$0.1411
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy